PeptideLabs Logo
PeptideLabs
Documentación de Calidad
Back to all 64 profiles
Community/research information onlyNo aprobado por FDA/EMA

Community protocol · MOTS-c

MOTS-c: community information and evidence, clearly separated.

A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.

Also known as: MOTS-c (Human) · Mitochondrial open reading frame peptide

Sources checked: 27 August 2026

Aviso importante de seguridad y responsabilidad

Esta página documenta y evalúa información de comunidades. No es consejo médico ni terapéutico, asesoramiento individual ni invitación al uso.

No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.

Quick context

MOTS-c

Se estudia en metabolismo energético celular, sensibilidad a la insulina, obesidad y biología ósea.

No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.

Amounts, timing and cycles

Community/research information only

No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.

Amount status

Different amounts circulate online; no regulator-confirmed safe or effective dose exists.

Profile evidence level: preclinical.

Timing

Community claims about time of day, fasting windows or training intervals are not validated clinical standards.

No individual recommendation.

Cycle/duration

Cycles and breaks are community constructs and do not prevent adverse effects or unknown long-term consequences.

No individual recommendation.

External community reference available

The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.

Open community source

Reconstitución y conversión U-100

Calculadora de reconstitución

For clearly identified single lyophilised substances, the calculator only shows the arithmetic between vial amount, liquid volume and target amount. It does not check identity, purity, sterility, solubility, stability or solvent suitability. The entered target is not a recommendation.

Calculadora de reconstitución

Calculates concentration, volume and theoretical U-100 units. The preloaded 200 µg is only the reference page's arithmetic example.

Concentration

3,333.33 µg/ml

Calculated volume

0.06 ml

U-100 units

6 U

Calculated portions per vial

50

Calculation aid, not dosage or use advice. Incorrect inputs, a different syringe scale, measurement error, dead space or unknown vial content produce incorrect results.

Mechanism and research questions

Mitochondrial-derived 16-amino-acid peptide

MOTS-c is classified as “Mitochondrial-derived 16-amino-acid peptide”. Se estudia en metabolismo energético celular, sensibilidad a la insulina, obesidad y biología ósea. This describes the investigated pathway but does not validate a community use, amount, route or combination.

01

Péptido mitocondrial

Los investigadores estudian cómo un péptido interactúa con las centrales energéticas de la célula, las mitocondrias, y afecta su producción de energía. Se miden, entre otras cosas, el consumo de oxígeno y el gasto energético en modelos celulares.

02

Metabolismo energético celular

Los investigadores estudian cómo las células producen y utilizan energía, en particular a través de las mitocondrias, de forma similar a medir la eficiencia con la que un motor quema combustible. Las medidas habituales incluyen el consumo de oxígeno y la producción de energía en modelos celulares.

03

Resultados en glucosa y apetito

Los investigadores estudian cómo una sustancia cambia los niveles de glucosa en sangre y la sensación de hambre a lo largo del día, de forma similar a observar la saciedad tras distintas comidas. Las medidas habituales incluyen lecturas de glucosa en sangre y cuestionarios sobre hambre e ingesta.

What communities discuss

These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.

Foros de biohacking y longevidad

Los usuarios comparan combinaciones de péptidos ensambladas por ellos mismos con el objetivo de influir en los procesos de envejecimiento o los niveles de energía, a menudo basándose en análisis de sangre o escalas subjetivas de bienestar. Los autoexperimentos personales y las promesas de marketing no reemplazan a los estudios controlados a largo plazo en humanos.

Anécdotas de energía y fatiga

Se reportan aumentos de energía percibidos subjetivamente tras usar péptidos mitocondriales o inyecciones de vitaminas, a menudo basándose en calificaciones personales de energía diaria. Estas impresiones están fuertemente influenciadas por efectos placebo.

Foros antienvejecimiento

Aquí se comparan combinaciones de péptidos del eje de crecimiento, mitocondriales y de la piel con el objetivo de influir en los signos visibles o percibidos del envejecimiento, a menudo documentados personalmente durante años. Las anécdotas y la publicidad de proveedores sobre el envejecimiento ralentizado no son una prueba científica.

Adverse effects and risk boundaries

  • Las vías energéticas y mitocondriales actúan en muchos órganos. Son posibles fatiga, cefalea y efectos circulatorios, metabólicos u orgánicos; los datos a largo plazo pueden ser limitados.
  • Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
  • A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.

Exclusion groups and professional assessment

  • Embarazo/lactancia y enfermedad cardíaca, hepática, renal o metabólica grave requieren valoración especializada según la indicación.
  • Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
  • Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.

Monitoring and laboratory markers

  • Según la pregunta pueden medirse constantes, capacidad funcional, lactato/marcadores metabólicos y función orgánica; fuera de estudios definidos suele no haber estándar.
  • Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.

Evidence boundary

Preclínico

La investigación es mayoritariamente preclínica; las afirmaciones sobre humanos siguen siendo provisionales.

Published evidence

Los datos disponibles provienen principalmente de modelos animales o celulares; faltan datos sólidos de eficacia y seguridad en humanos.

MOTS-c está codificado por el ADN mitocondrial, mientras que la elamipretida es un tetrapéptido sintético que se une a las mitocondrias.

Storage and stability

  • The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
  • Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
  • Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.

Troubleshooting and error sources

  • U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
  • Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
  • Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
  • Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.

Regulatory status and WADA

No aprobado por FDA/EMA

No existe medicamento aprobado por FDA o EMA; eficacia y seguridad no están establecidas.

WADA 2026

The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.

WADA — 2026 Prohibited List

Combinations / stacks

  • Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
  • Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
  • Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.

Frequently asked questions

Is an amount shown here a recommendation?

No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.

Does the U-100 calculator prove correct use?

No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.

Can this profile be combined with other substances?

Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.

Which source controls when information conflicts?

For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.

Are community claims clinical evidence?

No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.